PATENT CLAIM ANALYSIS

Application Number: 15922729
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "165000"]

Abstract:
Provided are compositions and methods for treating multiple sclerosis (MS). One embodiment of the disclosed method entails orally administering to a MS patient a first amount of aspirin and a second amount of fumaric acid or an ester or a salt thereof. In some embodiments, the aspirin is administered at from about 80 mg to about 500 mg per day and the fumaric acid or ester or salt thereof is administered at about 360 mg per day.

Claim (Index 11):
The capsule of  claim 10 , wherein the second dose of aspirin is from about 20 mg to about 500 mg.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.62745
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15686352', '15299535', '15582913', '15125612', '12529674']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7778127541081182
- 35 USC 102 Novelty (BERT): 0.5031930693724637
- Combined Prediction Score: 0.7503507856345528
- Mean Citation Score: 221.713856
- Max Citation Score: 225.8658
- Similarity Product: 149.84615562511684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test